RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Effective tax rate (%)

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndEffective tax rate (%) (Million USD)YoY (%)
Dec 31, 2024-52.6-4793.19%
Dec 31, 20231.1-94.61%
Dec 31, 202220.8-35.09%
Dec 31, 202132.1+740.99%
Dec 31, 20203.8-82.65%
Dec 31, 201922+192.57%
Dec 31, 20187.5-28.58%
Dec 31, 201710.5-83.37%
Dec 31, 201663.2+134.56%
Dec 31, 201527+65.93%
Dec 31, 201416.2-572.24%
Dec 31, 2013-3.4-54.33%
Dec 31, 2012-7.5-275.30%
Dec 31, 20114.3-44.65%
Dec 31, 20107.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)